MOTEK MEDICAL BV

Their core work

Motek Medical is a Dutch medical technology company specializing in virtual reality-based rehabilitation and human movement analysis systems. Their core products — including instrumented treadmills, force plates, and the CAREN (Computer Assisted Rehabilitation ENvironment) platform — allow clinicians and researchers to assess and retrain motor function in controlled, reproducible virtual environments. In H2020, they contributed industrial expertise to academic training networks focused on sensorimotor integration and age-related motor decline, bridging laboratory neuroscience with real-world rehabilitation technology. Their value to research consortia lies in providing access to commercial rehabilitation hardware and translational know-how that academic partners typically lack.

What they specialise in

How they've shifted over time

Motek Medical's early H2020 involvement (PACE, 2015) centred on fundamental sensorimotor science — understanding how the human nervous system integrates perception and movement in complex environments. Their second project (Keep Control, 2017) shifted toward a more clinical and demographic target: age-related motor decline and its diagnosis and treatment. This trajectory suggests a move from basic neuroscience infrastructure toward applied clinical rehabilitation, which aligns with the commercial direction of their product line. With no keywords recorded for the recent period and only two projects total, the trend is suggestive rather than conclusive.

Motek Medical appears to be moving from providing research infrastructure for fundamental neuroscience toward applying their systems in targeted clinical populations, particularly older adults with motor impairments — a commercially growing segment.

How they like to work

Motek Medical participates exclusively as a consortium partner, never as project coordinator — consistent with an SME providing specialist industrial capacity rather than leading research agendas. Their two projects were both large MSCA training networks, meaning they engaged with broad, multi-institutional consortia of 10+ partners across multiple countries. This suggests they are comfortable operating within complex, academically-led structures where their role is to provide applied expertise and host PhD secondments rather than drive project strategy.

Motek Medical has collaborated with 19 unique partners across 10 countries through just two projects, indicating they entered large, geographically diverse training networks rather than tight bilateral partnerships. Their network is European in scope, consistent with MSCA-ETN requirements for transnational consortium composition.

What sets them apart

Motek Medical occupies a rare niche as a commercial rehabilitation hardware manufacturer that actively participates in academic research consortia — giving them direct exposure to cutting-edge neuroscience while feeding insights back into product development. Few SMEs in the rehabilitation space combine force-plate treadmill manufacturing with VR environment software and a track record of hosting MSCA fellows, making them a credible industrial partner for any consortium needing both physical measurement infrastructure and translational grounding. For a consortium builder, they offer what most university labs cannot: a commercial pathway from research prototype to clinical product.

Highlights from their portfolio

• PACE
  Motek Medical's entry into H2020 research, directly tied to their core technology domain of sensorimotor integration and naturalistic movement stimulation — the scientific foundation of their rehabilitation platform products.
• Keep Control
  Focused on age-related motor decline diagnosis and treatment, representing a clinically and commercially significant population where Motek's systems have direct application and market relevance.